nodes	percent_of_prediction	percent_of_DWPC	metapath
Aripiprazole—schizophrenia—Dimenhydrinate—atopic dermatitis	0.257	0.569	CpDpCtD
Aripiprazole—schizophrenia—Diphenhydramine—atopic dermatitis	0.195	0.431	CpDpCtD
Aripiprazole—CHRM2—Dimenhydrinate—atopic dermatitis	0.0359	0.111	CbGbCtD
Aripiprazole—HRH1—Dimenhydrinate—atopic dermatitis	0.0328	0.101	CbGbCtD
Aripiprazole—KCNH2—Loratadine—atopic dermatitis	0.0272	0.084	CbGbCtD
Aripiprazole—CYP3A7-CYP3A51P—Tacrolimus—atopic dermatitis	0.019	0.0587	CbGbCtD
Aripiprazole—CYP3A7—Tacrolimus—atopic dermatitis	0.019	0.0587	CbGbCtD
Aripiprazole—CHRM2—Diphenhydramine—atopic dermatitis	0.0175	0.0542	CbGbCtD
Aripiprazole—HRH1—Loratadine—atopic dermatitis	0.016	0.0495	CbGbCtD
Aripiprazole—HRH1—Diphenhydramine—atopic dermatitis	0.016	0.0495	CbGbCtD
Aripiprazole—CYP3A5—Tacrolimus—atopic dermatitis	0.0142	0.044	CbGbCtD
Aripiprazole—CYP3A4—Pimecrolimus—atopic dermatitis	0.00934	0.0289	CbGbCtD
Aripiprazole—ABCB1—Tacrolimus—atopic dermatitis	0.00927	0.0287	CbGbCtD
Aripiprazole—CYP3A7-CYP3A51P—Hydrocortisone—atopic dermatitis	0.00773	0.0239	CbGbCtD
Aripiprazole—CYP3A7—Hydrocortisone—atopic dermatitis	0.00773	0.0239	CbGbCtD
Aripiprazole—ABCB1—Loratadine—atopic dermatitis	0.00679	0.021	CbGbCtD
Aripiprazole—DRD5—eyelid—atopic dermatitis	0.00649	0.342	CbGeAlD
Aripiprazole—CYP2D6—Loratadine—atopic dermatitis	0.00639	0.0198	CbGbCtD
Aripiprazole—CYP2D6—Diphenhydramine—atopic dermatitis	0.00639	0.0198	CbGbCtD
Aripiprazole—ABCB1—Methylprednisolone—atopic dermatitis	0.00621	0.0192	CbGbCtD
Aripiprazole—CYP3A5—Hydrocortisone—atopic dermatitis	0.0058	0.0179	CbGbCtD
Aripiprazole—CYP3A4—Tacrolimus—atopic dermatitis	0.00555	0.0172	CbGbCtD
Aripiprazole—CYP3A7-CYP3A51P—Dexamethasone—atopic dermatitis	0.00481	0.0149	CbGbCtD
Aripiprazole—CYP3A7—Dexamethasone—atopic dermatitis	0.00481	0.0149	CbGbCtD
Aripiprazole—CYP3A4—Loratadine—atopic dermatitis	0.00407	0.0126	CbGbCtD
Aripiprazole—ABCB1—Betamethasone—atopic dermatitis	0.00404	0.0125	CbGbCtD
Aripiprazole—ABCB1—Prednisolone—atopic dermatitis	0.00398	0.0123	CbGbCtD
Aripiprazole—ABCB1—Hydrocortisone—atopic dermatitis	0.00377	0.0117	CbGbCtD
Aripiprazole—ABCB1—Prednisone—atopic dermatitis	0.00376	0.0116	CbGbCtD
Aripiprazole—CYP3A4—Methylprednisolone—atopic dermatitis	0.00372	0.0115	CbGbCtD
Aripiprazole—CYP3A5—Dexamethasone—atopic dermatitis	0.00361	0.0111	CbGbCtD
Aripiprazole—CYP3A4—Triamcinolone—atopic dermatitis	0.00282	0.00871	CbGbCtD
Aripiprazole—CYP3A4—Betamethasone—atopic dermatitis	0.00242	0.00747	CbGbCtD
Aripiprazole—CYP3A4—Prednisolone—atopic dermatitis	0.00239	0.00737	CbGbCtD
Aripiprazole—ABCB1—Dexamethasone—atopic dermatitis	0.00235	0.00725	CbGbCtD
Aripiprazole—CYP3A4—Hydrocortisone—atopic dermatitis	0.00226	0.00699	CbGbCtD
Aripiprazole—CYP3A4—Prednisone—atopic dermatitis	0.00225	0.00696	CbGbCtD
Aripiprazole—CYP2D6—Dexamethasone—atopic dermatitis	0.00221	0.00684	CbGbCtD
Aripiprazole—CHRM5—skin epidermis—atopic dermatitis	0.00182	0.0958	CbGeAlD
Aripiprazole—CYP3A4—Dexamethasone—atopic dermatitis	0.00141	0.00435	CbGbCtD
Aripiprazole—H1F0—neck—atopic dermatitis	0.000751	0.0396	CbGeAlD
Aripiprazole—CHRM5—skin of body—atopic dermatitis	0.000564	0.0297	CbGeAlD
Aripiprazole—HTR1E—head—atopic dermatitis	0.000537	0.0283	CbGeAlD
Aripiprazole—H1F0—skin of body—atopic dermatitis	0.000486	0.0256	CbGeAlD
Aripiprazole—CHRM4—head—atopic dermatitis	0.000471	0.0248	CbGeAlD
Aripiprazole—HTR7—neck—atopic dermatitis	0.000464	0.0244	CbGeAlD
Aripiprazole—DRD3—head—atopic dermatitis	0.000437	0.023	CbGeAlD
Aripiprazole—HTR6—head—atopic dermatitis	0.000421	0.0222	CbGeAlD
Aripiprazole—DRD5—head—atopic dermatitis	0.00041	0.0216	CbGeAlD
Aripiprazole—CHRM5—head—atopic dermatitis	0.000368	0.0194	CbGeAlD
Aripiprazole—HTR2B—skin of body—atopic dermatitis	0.00035	0.0184	CbGeAlD
Aripiprazole—ADRA1B—head—atopic dermatitis	0.000336	0.0177	CbGeAlD
Aripiprazole—H1F0—head—atopic dermatitis	0.000317	0.0167	CbGeAlD
Aripiprazole—DRD1—head—atopic dermatitis	0.000313	0.0165	CbGeAlD
Aripiprazole—HTR3A—head—atopic dermatitis	0.000303	0.0159	CbGeAlD
Aripiprazole—HTR2A—neck—atopic dermatitis	0.000289	0.0152	CbGeAlD
Aripiprazole—HTR1B—head—atopic dermatitis	0.000254	0.0134	CbGeAlD
Aripiprazole—CHRM2—head—atopic dermatitis	0.000252	0.0133	CbGeAlD
Aripiprazole—HTR1D—head—atopic dermatitis	0.000246	0.0129	CbGeAlD
Aripiprazole—HTR2C—head—atopic dermatitis	0.000243	0.0128	CbGeAlD
Aripiprazole—ADRB1—head—atopic dermatitis	0.000239	0.0126	CbGeAlD
Aripiprazole—SLC6A4—head—atopic dermatitis	0.000231	0.0121	CbGeAlD
Aripiprazole—CHRM1—head—atopic dermatitis	0.00023	0.0121	CbGeAlD
Aripiprazole—HTR2B—head—atopic dermatitis	0.000229	0.012	CbGeAlD
Aripiprazole—CHRM3—head—atopic dermatitis	0.000206	0.0108	CbGeAlD
Aripiprazole—HTR1A—head—atopic dermatitis	0.000205	0.0108	CbGeAlD
Aripiprazole—HTR7—head—atopic dermatitis	0.000196	0.0103	CbGeAlD
Aripiprazole—ADRA1A—head—atopic dermatitis	0.000189	0.00994	CbGeAlD
Aripiprazole—DRD2—head—atopic dermatitis	0.000185	0.00974	CbGeAlD
Aripiprazole—KCNH2—head—atopic dermatitis	0.000182	0.0096	CbGeAlD
Aripiprazole—ADRA2C—head—atopic dermatitis	0.00018	0.00947	CbGeAlD
Aripiprazole—HRH1—head—atopic dermatitis	0.000146	0.0077	CbGeAlD
Aripiprazole—ADRA2A—head—atopic dermatitis	0.000144	0.00756	CbGeAlD
Aripiprazole—HTR2A—head—atopic dermatitis	0.000122	0.00643	CbGeAlD
Aripiprazole—CYP2D6—head—atopic dermatitis	0.000111	0.00586	CbGeAlD
Aripiprazole—ABCB1—head—atopic dermatitis	8e-05	0.00421	CbGeAlD
Aripiprazole—Tachycardia—Prednisolone—atopic dermatitis	2.32e-05	0.000154	CcSEcCtD
Aripiprazole—Convulsion—Methylprednisolone—atopic dermatitis	2.31e-05	0.000154	CcSEcCtD
Aripiprazole—Hypertension—Triamcinolone—atopic dermatitis	2.31e-05	0.000154	CcSEcCtD
Aripiprazole—Hypertension—Methylprednisolone—atopic dermatitis	2.31e-05	0.000153	CcSEcCtD
Aripiprazole—Infection—Hydrocortisone—atopic dermatitis	2.31e-05	0.000153	CcSEcCtD
Aripiprazole—Hyperhidrosis—Prednisolone—atopic dermatitis	2.3e-05	0.000153	CcSEcCtD
Aripiprazole—Shock—Hydrocortisone—atopic dermatitis	2.28e-05	0.000152	CcSEcCtD
Aripiprazole—Myalgia—Triamcinolone—atopic dermatitis	2.28e-05	0.000151	CcSEcCtD
Aripiprazole—Nervous system disorder—Hydrocortisone—atopic dermatitis	2.28e-05	0.000151	CcSEcCtD
Aripiprazole—Arthralgia—Methylprednisolone—atopic dermatitis	2.27e-05	0.000151	CcSEcCtD
Aripiprazole—Myalgia—Methylprednisolone—atopic dermatitis	2.27e-05	0.000151	CcSEcCtD
Aripiprazole—Eye disorder—Prednisone—atopic dermatitis	2.27e-05	0.000151	CcSEcCtD
Aripiprazole—Anxiety—Methylprednisolone—atopic dermatitis	2.27e-05	0.000151	CcSEcCtD
Aripiprazole—Tachycardia—Hydrocortisone—atopic dermatitis	2.27e-05	0.000151	CcSEcCtD
Aripiprazole—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—atopic dermatitis	2.26e-05	0.00015	CcSEcCtD
Aripiprazole—Flushing—Prednisone—atopic dermatitis	2.26e-05	0.00015	CcSEcCtD
Aripiprazole—Skin disorder—Hydrocortisone—atopic dermatitis	2.25e-05	0.00015	CcSEcCtD
Aripiprazole—Ill-defined disorder—Betamethasone—atopic dermatitis	2.25e-05	0.00015	CcSEcCtD
Aripiprazole—Ill-defined disorder—Dexamethasone—atopic dermatitis	2.25e-05	0.00015	CcSEcCtD
Aripiprazole—Discomfort—Triamcinolone—atopic dermatitis	2.25e-05	0.00015	CcSEcCtD
Aripiprazole—Discomfort—Methylprednisolone—atopic dermatitis	2.25e-05	0.000149	CcSEcCtD
Aripiprazole—Hyperhidrosis—Hydrocortisone—atopic dermatitis	2.24e-05	0.000149	CcSEcCtD
Aripiprazole—Dry mouth—Triamcinolone—atopic dermatitis	2.23e-05	0.000148	CcSEcCtD
Aripiprazole—Angioedema—Dexamethasone—atopic dermatitis	2.22e-05	0.000148	CcSEcCtD
Aripiprazole—Angioedema—Betamethasone—atopic dermatitis	2.22e-05	0.000148	CcSEcCtD
Aripiprazole—Anorexia—Hydrocortisone—atopic dermatitis	2.21e-05	0.000147	CcSEcCtD
Aripiprazole—Nausea—Tacrolimus—atopic dermatitis	2.21e-05	0.000147	CcSEcCtD
Aripiprazole—Angiopathy—Prednisone—atopic dermatitis	2.21e-05	0.000147	CcSEcCtD
Aripiprazole—Confusional state—Methylprednisolone—atopic dermatitis	2.2e-05	0.000146	CcSEcCtD
Aripiprazole—Immune system disorder—Prednisone—atopic dermatitis	2.2e-05	0.000146	CcSEcCtD
Aripiprazole—Malaise—Dexamethasone—atopic dermatitis	2.19e-05	0.000146	CcSEcCtD
Aripiprazole—Malaise—Betamethasone—atopic dermatitis	2.19e-05	0.000146	CcSEcCtD
Aripiprazole—Anaphylactic shock—Triamcinolone—atopic dermatitis	2.19e-05	0.000145	CcSEcCtD
Aripiprazole—Oedema—Triamcinolone—atopic dermatitis	2.19e-05	0.000145	CcSEcCtD
Aripiprazole—Vertigo—Dexamethasone—atopic dermatitis	2.18e-05	0.000145	CcSEcCtD
Aripiprazole—Vertigo—Betamethasone—atopic dermatitis	2.18e-05	0.000145	CcSEcCtD
Aripiprazole—Anaphylactic shock—Methylprednisolone—atopic dermatitis	2.18e-05	0.000145	CcSEcCtD
Aripiprazole—Syncope—Dexamethasone—atopic dermatitis	2.18e-05	0.000145	CcSEcCtD
Aripiprazole—Syncope—Betamethasone—atopic dermatitis	2.18e-05	0.000145	CcSEcCtD
Aripiprazole—Infection—Triamcinolone—atopic dermatitis	2.17e-05	0.000144	CcSEcCtD
Aripiprazole—Hypotension—Hydrocortisone—atopic dermatitis	2.17e-05	0.000144	CcSEcCtD
Aripiprazole—Infection—Methylprednisolone—atopic dermatitis	2.17e-05	0.000144	CcSEcCtD
Aripiprazole—Shock—Triamcinolone—atopic dermatitis	2.15e-05	0.000143	CcSEcCtD
Aripiprazole—Insomnia—Prednisolone—atopic dermatitis	2.15e-05	0.000143	CcSEcCtD
Aripiprazole—Alopecia—Prednisone—atopic dermatitis	2.15e-05	0.000143	CcSEcCtD
Aripiprazole—Shock—Methylprednisolone—atopic dermatitis	2.15e-05	0.000143	CcSEcCtD
Aripiprazole—Nervous system disorder—Methylprednisolone—atopic dermatitis	2.14e-05	0.000142	CcSEcCtD
Aripiprazole—Loss of consciousness—Betamethasone—atopic dermatitis	2.14e-05	0.000142	CcSEcCtD
Aripiprazole—Loss of consciousness—Dexamethasone—atopic dermatitis	2.14e-05	0.000142	CcSEcCtD
Aripiprazole—Paraesthesia—Prednisolone—atopic dermatitis	2.13e-05	0.000142	CcSEcCtD
Aripiprazole—Tachycardia—Triamcinolone—atopic dermatitis	2.13e-05	0.000142	CcSEcCtD
Aripiprazole—Mental disorder—Prednisone—atopic dermatitis	2.13e-05	0.000141	CcSEcCtD
Aripiprazole—Tachycardia—Methylprednisolone—atopic dermatitis	2.13e-05	0.000141	CcSEcCtD
Aripiprazole—Skin disorder—Methylprednisolone—atopic dermatitis	2.12e-05	0.000141	CcSEcCtD
Aripiprazole—Malnutrition—Prednisone—atopic dermatitis	2.12e-05	0.000141	CcSEcCtD
Aripiprazole—Erythema—Prednisone—atopic dermatitis	2.12e-05	0.000141	CcSEcCtD
Aripiprazole—Musculoskeletal discomfort—Hydrocortisone—atopic dermatitis	2.11e-05	0.000141	CcSEcCtD
Aripiprazole—Hyperhidrosis—Triamcinolone—atopic dermatitis	2.11e-05	0.00014	CcSEcCtD
Aripiprazole—Hyperhidrosis—Methylprednisolone—atopic dermatitis	2.11e-05	0.00014	CcSEcCtD
Aripiprazole—Convulsion—Dexamethasone—atopic dermatitis	2.11e-05	0.00014	CcSEcCtD
Aripiprazole—Convulsion—Betamethasone—atopic dermatitis	2.11e-05	0.00014	CcSEcCtD
Aripiprazole—Insomnia—Hydrocortisone—atopic dermatitis	2.1e-05	0.000139	CcSEcCtD
Aripiprazole—Hypertension—Betamethasone—atopic dermatitis	2.1e-05	0.000139	CcSEcCtD
Aripiprazole—Hypertension—Dexamethasone—atopic dermatitis	2.1e-05	0.000139	CcSEcCtD
Aripiprazole—Paraesthesia—Hydrocortisone—atopic dermatitis	2.08e-05	0.000138	CcSEcCtD
Aripiprazole—Myalgia—Dexamethasone—atopic dermatitis	2.07e-05	0.000137	CcSEcCtD
Aripiprazole—Myalgia—Betamethasone—atopic dermatitis	2.07e-05	0.000137	CcSEcCtD
Aripiprazole—Anxiety—Dexamethasone—atopic dermatitis	2.06e-05	0.000137	CcSEcCtD
Aripiprazole—Anxiety—Betamethasone—atopic dermatitis	2.06e-05	0.000137	CcSEcCtD
Aripiprazole—Discomfort—Dexamethasone—atopic dermatitis	2.04e-05	0.000136	CcSEcCtD
Aripiprazole—Discomfort—Betamethasone—atopic dermatitis	2.04e-05	0.000136	CcSEcCtD
Aripiprazole—Dyspepsia—Hydrocortisone—atopic dermatitis	2.04e-05	0.000136	CcSEcCtD
Aripiprazole—Hypotension—Methylprednisolone—atopic dermatitis	2.04e-05	0.000135	CcSEcCtD
Aripiprazole—Pain—Prednisolone—atopic dermatitis	2.03e-05	0.000135	CcSEcCtD
Aripiprazole—Decreased appetite—Hydrocortisone—atopic dermatitis	2.02e-05	0.000134	CcSEcCtD
Aripiprazole—Gastrointestinal disorder—Hydrocortisone—atopic dermatitis	2e-05	0.000133	CcSEcCtD
Aripiprazole—Fatigue—Hydrocortisone—atopic dermatitis	2e-05	0.000133	CcSEcCtD
Aripiprazole—Vision blurred—Prednisone—atopic dermatitis	1.99e-05	0.000132	CcSEcCtD
Aripiprazole—Musculoskeletal discomfort—Triamcinolone—atopic dermatitis	1.99e-05	0.000132	CcSEcCtD
Aripiprazole—Musculoskeletal discomfort—Methylprednisolone—atopic dermatitis	1.99e-05	0.000132	CcSEcCtD
Aripiprazole—Pain—Hydrocortisone—atopic dermatitis	1.98e-05	0.000132	CcSEcCtD
Aripiprazole—Oedema—Betamethasone—atopic dermatitis	1.98e-05	0.000132	CcSEcCtD
Aripiprazole—Anaphylactic shock—Betamethasone—atopic dermatitis	1.98e-05	0.000132	CcSEcCtD
Aripiprazole—Anaphylactic shock—Dexamethasone—atopic dermatitis	1.98e-05	0.000132	CcSEcCtD
Aripiprazole—Oedema—Dexamethasone—atopic dermatitis	1.98e-05	0.000132	CcSEcCtD
Aripiprazole—Insomnia—Triamcinolone—atopic dermatitis	1.98e-05	0.000131	CcSEcCtD
Aripiprazole—Insomnia—Methylprednisolone—atopic dermatitis	1.97e-05	0.000131	CcSEcCtD
Aripiprazole—Infection—Dexamethasone—atopic dermatitis	1.97e-05	0.000131	CcSEcCtD
Aripiprazole—Infection—Betamethasone—atopic dermatitis	1.97e-05	0.000131	CcSEcCtD
Aripiprazole—Ill-defined disorder—Prednisone—atopic dermatitis	1.96e-05	0.00013	CcSEcCtD
Aripiprazole—Paraesthesia—Triamcinolone—atopic dermatitis	1.96e-05	0.00013	CcSEcCtD
Aripiprazole—Feeling abnormal—Prednisolone—atopic dermatitis	1.96e-05	0.00013	CcSEcCtD
Aripiprazole—Paraesthesia—Methylprednisolone—atopic dermatitis	1.96e-05	0.00013	CcSEcCtD
Aripiprazole—Anaemia—Prednisone—atopic dermatitis	1.96e-05	0.00013	CcSEcCtD
Aripiprazole—Shock—Betamethasone—atopic dermatitis	1.95e-05	0.00013	CcSEcCtD
Aripiprazole—Shock—Dexamethasone—atopic dermatitis	1.95e-05	0.00013	CcSEcCtD
Aripiprazole—Dyspnoea—Triamcinolone—atopic dermatitis	1.95e-05	0.000129	CcSEcCtD
Aripiprazole—Nervous system disorder—Betamethasone—atopic dermatitis	1.94e-05	0.000129	CcSEcCtD
Aripiprazole—Nervous system disorder—Dexamethasone—atopic dermatitis	1.94e-05	0.000129	CcSEcCtD
Aripiprazole—Agitation—Prednisone—atopic dermatitis	1.94e-05	0.000129	CcSEcCtD
Aripiprazole—Thrombocytopenia—Dexamethasone—atopic dermatitis	1.94e-05	0.000129	CcSEcCtD
Aripiprazole—Thrombocytopenia—Betamethasone—atopic dermatitis	1.94e-05	0.000129	CcSEcCtD
Aripiprazole—Tachycardia—Dexamethasone—atopic dermatitis	1.94e-05	0.000129	CcSEcCtD
Aripiprazole—Tachycardia—Betamethasone—atopic dermatitis	1.94e-05	0.000129	CcSEcCtD
Aripiprazole—Angioedema—Prednisone—atopic dermatitis	1.93e-05	0.000128	CcSEcCtD
Aripiprazole—Dyspepsia—Triamcinolone—atopic dermatitis	1.92e-05	0.000128	CcSEcCtD
Aripiprazole—Dyspepsia—Methylprednisolone—atopic dermatitis	1.92e-05	0.000128	CcSEcCtD
Aripiprazole—Hyperhidrosis—Dexamethasone—atopic dermatitis	1.92e-05	0.000127	CcSEcCtD
Aripiprazole—Hyperhidrosis—Betamethasone—atopic dermatitis	1.92e-05	0.000127	CcSEcCtD
Aripiprazole—Feeling abnormal—Hydrocortisone—atopic dermatitis	1.91e-05	0.000127	CcSEcCtD
Aripiprazole—Malaise—Prednisone—atopic dermatitis	1.91e-05	0.000127	CcSEcCtD
Aripiprazole—Vertigo—Prednisone—atopic dermatitis	1.9e-05	0.000126	CcSEcCtD
Aripiprazole—Gastrointestinal pain—Hydrocortisone—atopic dermatitis	1.9e-05	0.000126	CcSEcCtD
Aripiprazole—Syncope—Prednisone—atopic dermatitis	1.9e-05	0.000126	CcSEcCtD
Aripiprazole—Anorexia—Betamethasone—atopic dermatitis	1.89e-05	0.000126	CcSEcCtD
Aripiprazole—Anorexia—Dexamethasone—atopic dermatitis	1.89e-05	0.000126	CcSEcCtD
Aripiprazole—Urticaria—Prednisolone—atopic dermatitis	1.89e-05	0.000125	CcSEcCtD
Aripiprazole—Fatigue—Triamcinolone—atopic dermatitis	1.88e-05	0.000125	CcSEcCtD
Aripiprazole—Fatigue—Methylprednisolone—atopic dermatitis	1.88e-05	0.000125	CcSEcCtD
Aripiprazole—Pain—Triamcinolone—atopic dermatitis	1.87e-05	0.000124	CcSEcCtD
Aripiprazole—Loss of consciousness—Prednisone—atopic dermatitis	1.86e-05	0.000124	CcSEcCtD
Aripiprazole—Hypotension—Betamethasone—atopic dermatitis	1.85e-05	0.000123	CcSEcCtD
Aripiprazole—Hypotension—Dexamethasone—atopic dermatitis	1.85e-05	0.000123	CcSEcCtD
Aripiprazole—Urticaria—Hydrocortisone—atopic dermatitis	1.84e-05	0.000123	CcSEcCtD
Aripiprazole—Abdominal pain—Hydrocortisone—atopic dermatitis	1.83e-05	0.000122	CcSEcCtD
Aripiprazole—Body temperature increased—Hydrocortisone—atopic dermatitis	1.83e-05	0.000122	CcSEcCtD
Aripiprazole—Convulsion—Prednisone—atopic dermatitis	1.83e-05	0.000122	CcSEcCtD
Aripiprazole—Hypertension—Prednisone—atopic dermatitis	1.83e-05	0.000121	CcSEcCtD
Aripiprazole—Musculoskeletal discomfort—Betamethasone—atopic dermatitis	1.81e-05	0.00012	CcSEcCtD
Aripiprazole—Musculoskeletal discomfort—Dexamethasone—atopic dermatitis	1.81e-05	0.00012	CcSEcCtD
Aripiprazole—Arthralgia—Prednisone—atopic dermatitis	1.8e-05	0.00012	CcSEcCtD
Aripiprazole—Myalgia—Prednisone—atopic dermatitis	1.8e-05	0.00012	CcSEcCtD
Aripiprazole—Feeling abnormal—Triamcinolone—atopic dermatitis	1.8e-05	0.00012	CcSEcCtD
Aripiprazole—Feeling abnormal—Methylprednisolone—atopic dermatitis	1.8e-05	0.000119	CcSEcCtD
Aripiprazole—Anxiety—Prednisone—atopic dermatitis	1.8e-05	0.000119	CcSEcCtD
Aripiprazole—Insomnia—Betamethasone—atopic dermatitis	1.79e-05	0.000119	CcSEcCtD
Aripiprazole—Insomnia—Dexamethasone—atopic dermatitis	1.79e-05	0.000119	CcSEcCtD
Aripiprazole—Unspecified disorder of skin and subcutaneous tissue—Prednisone—atopic dermatitis	1.79e-05	0.000119	CcSEcCtD
Aripiprazole—Gastrointestinal pain—Methylprednisolone—atopic dermatitis	1.78e-05	0.000118	CcSEcCtD
Aripiprazole—Paraesthesia—Betamethasone—atopic dermatitis	1.78e-05	0.000118	CcSEcCtD
Aripiprazole—Paraesthesia—Dexamethasone—atopic dermatitis	1.78e-05	0.000118	CcSEcCtD
Aripiprazole—Discomfort—Prednisone—atopic dermatitis	1.78e-05	0.000118	CcSEcCtD
Aripiprazole—Hypersensitivity—Prednisolone—atopic dermatitis	1.75e-05	0.000116	CcSEcCtD
Aripiprazole—Dyspepsia—Betamethasone—atopic dermatitis	1.75e-05	0.000116	CcSEcCtD
Aripiprazole—Dyspepsia—Dexamethasone—atopic dermatitis	1.75e-05	0.000116	CcSEcCtD
Aripiprazole—Urticaria—Triamcinolone—atopic dermatitis	1.74e-05	0.000115	CcSEcCtD
Aripiprazole—Urticaria—Methylprednisolone—atopic dermatitis	1.73e-05	0.000115	CcSEcCtD
Aripiprazole—Body temperature increased—Triamcinolone—atopic dermatitis	1.73e-05	0.000115	CcSEcCtD
Aripiprazole—Oedema—Prednisone—atopic dermatitis	1.73e-05	0.000115	CcSEcCtD
Aripiprazole—Anaphylactic shock—Prednisone—atopic dermatitis	1.73e-05	0.000115	CcSEcCtD
Aripiprazole—Abdominal pain—Methylprednisolone—atopic dermatitis	1.72e-05	0.000115	CcSEcCtD
Aripiprazole—Decreased appetite—Dexamethasone—atopic dermatitis	1.72e-05	0.000115	CcSEcCtD
Aripiprazole—Decreased appetite—Betamethasone—atopic dermatitis	1.72e-05	0.000115	CcSEcCtD
Aripiprazole—Infection—Prednisone—atopic dermatitis	1.72e-05	0.000114	CcSEcCtD
Aripiprazole—Gastrointestinal disorder—Betamethasone—atopic dermatitis	1.71e-05	0.000114	CcSEcCtD
Aripiprazole—Gastrointestinal disorder—Dexamethasone—atopic dermatitis	1.71e-05	0.000114	CcSEcCtD
Aripiprazole—Hypersensitivity—Hydrocortisone—atopic dermatitis	1.71e-05	0.000114	CcSEcCtD
Aripiprazole—Fatigue—Betamethasone—atopic dermatitis	1.71e-05	0.000114	CcSEcCtD
Aripiprazole—Fatigue—Dexamethasone—atopic dermatitis	1.71e-05	0.000114	CcSEcCtD
Aripiprazole—Shock—Prednisone—atopic dermatitis	1.7e-05	0.000113	CcSEcCtD
Aripiprazole—Pain—Betamethasone—atopic dermatitis	1.7e-05	0.000113	CcSEcCtD
Aripiprazole—Pain—Dexamethasone—atopic dermatitis	1.7e-05	0.000113	CcSEcCtD
Aripiprazole—Nervous system disorder—Prednisone—atopic dermatitis	1.69e-05	0.000113	CcSEcCtD
Aripiprazole—Tachycardia—Prednisone—atopic dermatitis	1.69e-05	0.000112	CcSEcCtD
Aripiprazole—Skin disorder—Prednisone—atopic dermatitis	1.68e-05	0.000111	CcSEcCtD
Aripiprazole—Hyperhidrosis—Prednisone—atopic dermatitis	1.67e-05	0.000111	CcSEcCtD
Aripiprazole—Asthenia—Hydrocortisone—atopic dermatitis	1.67e-05	0.000111	CcSEcCtD
Aripiprazole—Anorexia—Prednisone—atopic dermatitis	1.65e-05	0.000109	CcSEcCtD
Aripiprazole—Pruritus—Hydrocortisone—atopic dermatitis	1.64e-05	0.000109	CcSEcCtD
Aripiprazole—Feeling abnormal—Dexamethasone—atopic dermatitis	1.63e-05	0.000109	CcSEcCtD
Aripiprazole—Feeling abnormal—Betamethasone—atopic dermatitis	1.63e-05	0.000109	CcSEcCtD
Aripiprazole—Gastrointestinal pain—Dexamethasone—atopic dermatitis	1.62e-05	0.000108	CcSEcCtD
Aripiprazole—Gastrointestinal pain—Betamethasone—atopic dermatitis	1.62e-05	0.000108	CcSEcCtD
Aripiprazole—Hypersensitivity—Triamcinolone—atopic dermatitis	1.61e-05	0.000107	CcSEcCtD
Aripiprazole—Hypersensitivity—Methylprednisolone—atopic dermatitis	1.61e-05	0.000107	CcSEcCtD
Aripiprazole—Diarrhoea—Hydrocortisone—atopic dermatitis	1.59e-05	0.000106	CcSEcCtD
Aripiprazole—Urticaria—Dexamethasone—atopic dermatitis	1.58e-05	0.000105	CcSEcCtD
Aripiprazole—Urticaria—Betamethasone—atopic dermatitis	1.58e-05	0.000105	CcSEcCtD
Aripiprazole—Musculoskeletal discomfort—Prednisone—atopic dermatitis	1.57e-05	0.000105	CcSEcCtD
Aripiprazole—Dizziness—Prednisolone—atopic dermatitis	1.57e-05	0.000104	CcSEcCtD
Aripiprazole—Asthenia—Triamcinolone—atopic dermatitis	1.57e-05	0.000104	CcSEcCtD
Aripiprazole—Abdominal pain—Betamethasone—atopic dermatitis	1.57e-05	0.000104	CcSEcCtD
Aripiprazole—Body temperature increased—Dexamethasone—atopic dermatitis	1.57e-05	0.000104	CcSEcCtD
Aripiprazole—Abdominal pain—Dexamethasone—atopic dermatitis	1.57e-05	0.000104	CcSEcCtD
Aripiprazole—Body temperature increased—Betamethasone—atopic dermatitis	1.57e-05	0.000104	CcSEcCtD
Aripiprazole—Asthenia—Methylprednisolone—atopic dermatitis	1.56e-05	0.000104	CcSEcCtD
Aripiprazole—Insomnia—Prednisone—atopic dermatitis	1.56e-05	0.000104	CcSEcCtD
Aripiprazole—Paraesthesia—Prednisone—atopic dermatitis	1.55e-05	0.000103	CcSEcCtD
Aripiprazole—Pruritus—Triamcinolone—atopic dermatitis	1.55e-05	0.000103	CcSEcCtD
Aripiprazole—Pruritus—Methylprednisolone—atopic dermatitis	1.54e-05	0.000103	CcSEcCtD
Aripiprazole—Dizziness—Hydrocortisone—atopic dermatitis	1.53e-05	0.000102	CcSEcCtD
Aripiprazole—Dyspepsia—Prednisone—atopic dermatitis	1.52e-05	0.000101	CcSEcCtD
Aripiprazole—Decreased appetite—Prednisone—atopic dermatitis	1.5e-05	9.97e-05	CcSEcCtD
Aripiprazole—Rash—Prednisolone—atopic dermatitis	1.5e-05	9.96e-05	CcSEcCtD
Aripiprazole—Dermatitis—Prednisolone—atopic dermatitis	1.5e-05	9.95e-05	CcSEcCtD
Aripiprazole—Diarrhoea—Methylprednisolone—atopic dermatitis	1.49e-05	9.91e-05	CcSEcCtD
Aripiprazole—Fatigue—Prednisone—atopic dermatitis	1.49e-05	9.89e-05	CcSEcCtD
Aripiprazole—Headache—Prednisolone—atopic dermatitis	1.49e-05	9.89e-05	CcSEcCtD
Aripiprazole—Constipation—Prednisone—atopic dermatitis	1.48e-05	9.81e-05	CcSEcCtD
Aripiprazole—Vomiting—Hydrocortisone—atopic dermatitis	1.48e-05	9.81e-05	CcSEcCtD
Aripiprazole—Rash—Hydrocortisone—atopic dermatitis	1.46e-05	9.72e-05	CcSEcCtD
Aripiprazole—Dermatitis—Hydrocortisone—atopic dermatitis	1.46e-05	9.71e-05	CcSEcCtD
Aripiprazole—Headache—Hydrocortisone—atopic dermatitis	1.45e-05	9.66e-05	CcSEcCtD
Aripiprazole—Dizziness—Triamcinolone—atopic dermatitis	1.45e-05	9.6e-05	CcSEcCtD
Aripiprazole—Dizziness—Methylprednisolone—atopic dermatitis	1.44e-05	9.58e-05	CcSEcCtD
Aripiprazole—Feeling abnormal—Prednisone—atopic dermatitis	1.42e-05	9.46e-05	CcSEcCtD
Aripiprazole—Asthenia—Betamethasone—atopic dermatitis	1.42e-05	9.45e-05	CcSEcCtD
Aripiprazole—Asthenia—Dexamethasone—atopic dermatitis	1.42e-05	9.45e-05	CcSEcCtD
Aripiprazole—Gastrointestinal pain—Prednisone—atopic dermatitis	1.41e-05	9.38e-05	CcSEcCtD
Aripiprazole—Nausea—Prednisolone—atopic dermatitis	1.41e-05	9.38e-05	CcSEcCtD
Aripiprazole—Pruritus—Dexamethasone—atopic dermatitis	1.4e-05	9.32e-05	CcSEcCtD
Aripiprazole—Pruritus—Betamethasone—atopic dermatitis	1.4e-05	9.32e-05	CcSEcCtD
Aripiprazole—Vomiting—Triamcinolone—atopic dermatitis	1.39e-05	9.23e-05	CcSEcCtD
Aripiprazole—Vomiting—Methylprednisolone—atopic dermatitis	1.39e-05	9.21e-05	CcSEcCtD
Aripiprazole—Nausea—Hydrocortisone—atopic dermatitis	1.38e-05	9.16e-05	CcSEcCtD
Aripiprazole—Rash—Triamcinolone—atopic dermatitis	1.38e-05	9.16e-05	CcSEcCtD
Aripiprazole—Dermatitis—Triamcinolone—atopic dermatitis	1.38e-05	9.15e-05	CcSEcCtD
Aripiprazole—Rash—Methylprednisolone—atopic dermatitis	1.37e-05	9.14e-05	CcSEcCtD
Aripiprazole—Dermatitis—Methylprednisolone—atopic dermatitis	1.37e-05	9.13e-05	CcSEcCtD
Aripiprazole—Urticaria—Prednisone—atopic dermatitis	1.37e-05	9.12e-05	CcSEcCtD
Aripiprazole—Headache—Triamcinolone—atopic dermatitis	1.37e-05	9.1e-05	CcSEcCtD
Aripiprazole—Headache—Methylprednisolone—atopic dermatitis	1.37e-05	9.08e-05	CcSEcCtD
Aripiprazole—Body temperature increased—Prednisone—atopic dermatitis	1.37e-05	9.07e-05	CcSEcCtD
Aripiprazole—Abdominal pain—Prednisone—atopic dermatitis	1.37e-05	9.07e-05	CcSEcCtD
Aripiprazole—Diarrhoea—Dexamethasone—atopic dermatitis	1.36e-05	9.01e-05	CcSEcCtD
Aripiprazole—Diarrhoea—Betamethasone—atopic dermatitis	1.36e-05	9.01e-05	CcSEcCtD
Aripiprazole—Dizziness—Dexamethasone—atopic dermatitis	1.31e-05	8.71e-05	CcSEcCtD
Aripiprazole—Dizziness—Betamethasone—atopic dermatitis	1.31e-05	8.71e-05	CcSEcCtD
Aripiprazole—Nausea—Triamcinolone—atopic dermatitis	1.3e-05	8.63e-05	CcSEcCtD
Aripiprazole—Nausea—Methylprednisolone—atopic dermatitis	1.3e-05	8.61e-05	CcSEcCtD
Aripiprazole—Hypersensitivity—Prednisone—atopic dermatitis	1.27e-05	8.45e-05	CcSEcCtD
Aripiprazole—Vomiting—Dexamethasone—atopic dermatitis	1.26e-05	8.38e-05	CcSEcCtD
Aripiprazole—Vomiting—Betamethasone—atopic dermatitis	1.26e-05	8.38e-05	CcSEcCtD
Aripiprazole—Rash—Dexamethasone—atopic dermatitis	1.25e-05	8.31e-05	CcSEcCtD
Aripiprazole—Rash—Betamethasone—atopic dermatitis	1.25e-05	8.31e-05	CcSEcCtD
Aripiprazole—Dermatitis—Dexamethasone—atopic dermatitis	1.25e-05	8.3e-05	CcSEcCtD
Aripiprazole—Dermatitis—Betamethasone—atopic dermatitis	1.25e-05	8.3e-05	CcSEcCtD
Aripiprazole—Headache—Betamethasone—atopic dermatitis	1.24e-05	8.25e-05	CcSEcCtD
Aripiprazole—Headache—Dexamethasone—atopic dermatitis	1.24e-05	8.25e-05	CcSEcCtD
Aripiprazole—Asthenia—Prednisone—atopic dermatitis	1.24e-05	8.23e-05	CcSEcCtD
Aripiprazole—Pruritus—Prednisone—atopic dermatitis	1.22e-05	8.12e-05	CcSEcCtD
Aripiprazole—Diarrhoea—Prednisone—atopic dermatitis	1.18e-05	7.85e-05	CcSEcCtD
Aripiprazole—Nausea—Betamethasone—atopic dermatitis	1.18e-05	7.83e-05	CcSEcCtD
Aripiprazole—Nausea—Dexamethasone—atopic dermatitis	1.18e-05	7.83e-05	CcSEcCtD
Aripiprazole—Dizziness—Prednisone—atopic dermatitis	1.14e-05	7.59e-05	CcSEcCtD
Aripiprazole—Vomiting—Prednisone—atopic dermatitis	1.1e-05	7.3e-05	CcSEcCtD
Aripiprazole—Rash—Prednisone—atopic dermatitis	1.09e-05	7.23e-05	CcSEcCtD
Aripiprazole—Dermatitis—Prednisone—atopic dermatitis	1.09e-05	7.23e-05	CcSEcCtD
Aripiprazole—Headache—Prednisone—atopic dermatitis	1.08e-05	7.19e-05	CcSEcCtD
Aripiprazole—Nausea—Prednisone—atopic dermatitis	1.03e-05	6.82e-05	CcSEcCtD
Aripiprazole—HRH1—Signaling Pathways—CXCL10—atopic dermatitis	4.83e-06	8.81e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—CCL5—atopic dermatitis	4.82e-06	8.79e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Metabolism—PPARA—atopic dermatitis	4.82e-06	8.79e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—CXCL10—atopic dermatitis	4.81e-06	8.78e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—CXCL10—atopic dermatitis	4.8e-06	8.75e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—CCL5—atopic dermatitis	4.8e-06	8.75e-05	CbGpPWpGaD
Aripiprazole—DRD4—Signaling Pathways—NFKBIA—atopic dermatitis	4.76e-06	8.68e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—CXCL10—atopic dermatitis	4.75e-06	8.67e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—CXCL10—atopic dermatitis	4.74e-06	8.64e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—GPCR downstream signaling—CXCL8—atopic dermatitis	4.74e-06	8.64e-05	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling Pathways—NFKBIA—atopic dermatitis	4.69e-06	8.56e-05	CbGpPWpGaD
Aripiprazole—HTR1A—GPCR downstream signaling—IL2—atopic dermatitis	4.68e-06	8.53e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—NGF—atopic dermatitis	4.67e-06	8.52e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—CCL5—atopic dermatitis	4.67e-06	8.51e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—GPCR downstream signaling—CXCL8—atopic dermatitis	4.66e-06	8.5e-05	CbGpPWpGaD
Aripiprazole—HTR2C—GPCR downstream signaling—IL2—atopic dermatitis	4.66e-06	8.49e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling by GPCR—CXCL8—atopic dermatitis	4.65e-06	8.48e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—NGF—atopic dermatitis	4.63e-06	8.44e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling by GPCR—CXCL8—atopic dermatitis	4.61e-06	8.4e-05	CbGpPWpGaD
Aripiprazole—DRD5—Signaling Pathways—CXCL8—atopic dermatitis	4.6e-06	8.38e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—CCL5—atopic dermatitis	4.59e-06	8.38e-05	CbGpPWpGaD
Aripiprazole—HTR1E—Signaling Pathways—MAPK8—atopic dermatitis	4.57e-06	8.33e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—CCR5—atopic dermatitis	4.54e-06	8.28e-05	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling Pathways—NFKBIA—atopic dermatitis	4.54e-06	8.28e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—GPCR downstream signaling—IL2—atopic dermatitis	4.53e-06	8.26e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—CCR5—atopic dermatitis	4.5e-06	8.21e-05	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling Pathways—NFKBIA—atopic dermatitis	4.5e-06	8.2e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—NGF—atopic dermatitis	4.47e-06	8.14e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—GPCR downstream signaling—IL2—atopic dermatitis	4.46e-06	8.13e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling by GPCR—CXCL8—atopic dermatitis	4.45e-06	8.11e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—NGF—atopic dermatitis	4.44e-06	8.1e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling by GPCR—IL2—atopic dermatitis	4.44e-06	8.1e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling by GPCR—CXCL8—atopic dermatitis	4.42e-06	8.07e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—CXCL10—atopic dermatitis	4.4e-06	8.03e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling by GPCR—IL2—atopic dermatitis	4.4e-06	8.03e-05	CbGpPWpGaD
Aripiprazole—DRD5—Signaling Pathways—IL2—atopic dermatitis	4.39e-06	8.01e-05	CbGpPWpGaD
Aripiprazole—DRD5—Signaling by GPCR—IL6—atopic dermatitis	4.37e-06	7.97e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—CCR5—atopic dermatitis	4.34e-06	7.92e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—CCR5—atopic dermatitis	4.32e-06	7.88e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—NGF—atopic dermatitis	4.32e-06	7.88e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling by GPCR—CXCL8—atopic dermatitis	4.3e-06	7.85e-05	CbGpPWpGaD
Aripiprazole—DRD2—GPCR downstream signaling—CXCL8—atopic dermatitis	4.3e-06	7.84e-05	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—NFKBIA—atopic dermatitis	4.28e-06	7.81e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Metabolism—PPARA—atopic dermatitis	4.27e-06	7.78e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—NGF—atopic dermatitis	4.25e-06	7.76e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling by GPCR—IL2—atopic dermatitis	4.25e-06	7.75e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling by GPCR—CXCL8—atopic dermatitis	4.23e-06	7.72e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—CCL5—atopic dermatitis	4.23e-06	7.72e-05	CbGpPWpGaD
Aripiprazole—HTR2A—GPCR downstream signaling—CXCL8—atopic dermatitis	4.23e-06	7.71e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling by GPCR—IL2—atopic dermatitis	4.23e-06	7.71e-05	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—NFKBIA—atopic dermatitis	4.23e-06	7.71e-05	CbGpPWpGaD
Aripiprazole—HRH1—GPCR downstream signaling—CXCL8—atopic dermatitis	4.22e-06	7.7e-05	CbGpPWpGaD
Aripiprazole—CHRM1—GPCR downstream signaling—CXCL8—atopic dermatitis	4.21e-06	7.67e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—CCR5—atopic dermatitis	4.2e-06	7.67e-05	CbGpPWpGaD
Aripiprazole—CHRM3—GPCR downstream signaling—CXCL8—atopic dermatitis	4.19e-06	7.65e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—CCL5—atopic dermatitis	4.17e-06	7.6e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—CCL5—atopic dermatitis	4.16e-06	7.58e-05	CbGpPWpGaD
Aripiprazole—CHRM2—GPCR downstream signaling—CXCL8—atopic dermatitis	4.15e-06	7.57e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—CCL5—atopic dermatitis	4.14e-06	7.56e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—GPCR downstream signaling—CXCL8—atopic dermatitis	4.14e-06	7.55e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—CCR5—atopic dermatitis	4.14e-06	7.55e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—CCL5—atopic dermatitis	4.13e-06	7.53e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling by GPCR—IL2—atopic dermatitis	4.11e-06	7.5e-05	CbGpPWpGaD
Aripiprazole—DRD2—GPCR downstream signaling—IL2—atopic dermatitis	4.11e-06	7.49e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—CCL5—atopic dermatitis	4.09e-06	7.46e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—CCL5—atopic dermatitis	4.08e-06	7.44e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling by GPCR—IL2—atopic dermatitis	4.05e-06	7.38e-05	CbGpPWpGaD
Aripiprazole—DRD5—Signaling Pathways—MAPK8—atopic dermatitis	4.04e-06	7.38e-05	CbGpPWpGaD
Aripiprazole—HTR2A—GPCR downstream signaling—IL2—atopic dermatitis	4.04e-06	7.37e-05	CbGpPWpGaD
Aripiprazole—HRH1—GPCR downstream signaling—IL2—atopic dermatitis	4.03e-06	7.36e-05	CbGpPWpGaD
Aripiprazole—CHRM1—GPCR downstream signaling—IL2—atopic dermatitis	4.02e-06	7.33e-05	CbGpPWpGaD
Aripiprazole—CHRM3—GPCR downstream signaling—IL2—atopic dermatitis	4.01e-06	7.31e-05	CbGpPWpGaD
Aripiprazole—CHRM2—GPCR downstream signaling—IL2—atopic dermatitis	3.97e-06	7.24e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—GPCR downstream signaling—IL2—atopic dermatitis	3.96e-06	7.22e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—NGF—atopic dermatitis	3.92e-06	7.15e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Metabolism—PPARA—atopic dermatitis	3.92e-06	7.14e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling by GPCR—CXCL8—atopic dermatitis	3.9e-06	7.12e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—NGF—atopic dermatitis	3.86e-06	7.04e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—NFKBIA—atopic dermatitis	3.85e-06	7.02e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—NGF—atopic dermatitis	3.85e-06	7.02e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—GPCR downstream signaling—CXCL8—atopic dermatitis	3.85e-06	7.02e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling by GPCR—CXCL8—atopic dermatitis	3.84e-06	7.01e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—NGF—atopic dermatitis	3.84e-06	7e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling by GPCR—CXCL8—atopic dermatitis	3.83e-06	6.99e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—NGF—atopic dermatitis	3.83e-06	6.98e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling by GPCR—CXCL8—atopic dermatitis	3.82e-06	6.97e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—NFKBIA—atopic dermatitis	3.82e-06	6.96e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—CCR5—atopic dermatitis	3.81e-06	6.96e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling by GPCR—CXCL8—atopic dermatitis	3.81e-06	6.95e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—CCL5—atopic dermatitis	3.79e-06	6.91e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—NGF—atopic dermatitis	3.79e-06	6.91e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—NGF—atopic dermatitis	3.78e-06	6.89e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling by GPCR—CXCL8—atopic dermatitis	3.77e-06	6.88e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling by GPCR—CXCL8—atopic dermatitis	3.76e-06	6.86e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—CCR5—atopic dermatitis	3.75e-06	6.84e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—CCR5—atopic dermatitis	3.75e-06	6.83e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—CCR5—atopic dermatitis	3.73e-06	6.81e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling by GPCR—IL2—atopic dermatitis	3.73e-06	6.8e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—CCR5—atopic dermatitis	3.72e-06	6.79e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—CCR5—atopic dermatitis	3.69e-06	6.72e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—NFKBIA—atopic dermatitis	3.68e-06	6.72e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—GPCR downstream signaling—IL2—atopic dermatitis	3.68e-06	6.71e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—CCR5—atopic dermatitis	3.68e-06	6.7e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling by GPCR—IL2—atopic dermatitis	3.67e-06	6.69e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—NFKBIA—atopic dermatitis	3.66e-06	6.68e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling by GPCR—IL2—atopic dermatitis	3.66e-06	6.68e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling by GPCR—IL2—atopic dermatitis	3.65e-06	6.66e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling by GPCR—IL2—atopic dermatitis	3.64e-06	6.64e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling by GPCR—IL2—atopic dermatitis	3.6e-06	6.57e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling by GPCR—IL2—atopic dermatitis	3.59e-06	6.56e-05	CbGpPWpGaD
Aripiprazole—CYP3A5—Metabolism—PPARA—atopic dermatitis	3.59e-06	6.54e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—NFKBIA—atopic dermatitis	3.56e-06	6.5e-05	CbGpPWpGaD
Aripiprazole—HTR6—Signaling Pathways—CXCL8—atopic dermatitis	3.55e-06	6.47e-05	CbGpPWpGaD
Aripiprazole—HTR7—Signaling Pathways—CXCL8—atopic dermatitis	3.54e-06	6.46e-05	CbGpPWpGaD
Aripiprazole—HTR1D—Signaling Pathways—CXCL8—atopic dermatitis	3.52e-06	6.42e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—NGF—atopic dermatitis	3.51e-06	6.4e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—NFKBIA—atopic dermatitis	3.51e-06	6.4e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling by GPCR—CXCL8—atopic dermatitis	3.5e-06	6.37e-05	CbGpPWpGaD
Aripiprazole—HTR1B—Signaling Pathways—CXCL8—atopic dermatitis	3.45e-06	6.29e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—CCR5—atopic dermatitis	3.41e-06	6.23e-05	CbGpPWpGaD
Aripiprazole—DRD4—Signaling Pathways—CXCL8—atopic dermatitis	3.39e-06	6.19e-05	CbGpPWpGaD
Aripiprazole—HTR6—Signaling Pathways—IL2—atopic dermatitis	3.39e-06	6.18e-05	CbGpPWpGaD
Aripiprazole—HTR7—Signaling Pathways—IL2—atopic dermatitis	3.39e-06	6.18e-05	CbGpPWpGaD
Aripiprazole—HTR6—Signaling by GPCR—IL6—atopic dermatitis	3.37e-06	6.15e-05	CbGpPWpGaD
Aripiprazole—HTR7—Signaling by GPCR—IL6—atopic dermatitis	3.37e-06	6.15e-05	CbGpPWpGaD
Aripiprazole—HTR1D—Signaling Pathways—IL2—atopic dermatitis	3.37e-06	6.14e-05	CbGpPWpGaD
Aripiprazole—HTR1D—Signaling by GPCR—IL6—atopic dermatitis	3.35e-06	6.11e-05	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling Pathways—CXCL8—atopic dermatitis	3.35e-06	6.1e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling by GPCR—IL2—atopic dermatitis	3.34e-06	6.09e-05	CbGpPWpGaD
Aripiprazole—HTR1B—Signaling Pathways—IL2—atopic dermatitis	3.3e-06	6.01e-05	CbGpPWpGaD
Aripiprazole—HTR1B—Signaling by GPCR—IL6—atopic dermatitis	3.28e-06	5.98e-05	CbGpPWpGaD
Aripiprazole—DRD4—Signaling Pathways—IL2—atopic dermatitis	3.24e-06	5.91e-05	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling Pathways—CXCL8—atopic dermatitis	3.24e-06	5.91e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—NFKBIA—atopic dermatitis	3.23e-06	5.9e-05	CbGpPWpGaD
Aripiprazole—DRD4—Signaling by GPCR—IL6—atopic dermatitis	3.23e-06	5.88e-05	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling Pathways—CXCL8—atopic dermatitis	3.21e-06	5.85e-05	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling Pathways—IL2—atopic dermatitis	3.2e-06	5.83e-05	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling by GPCR—IL6—atopic dermatitis	3.18e-06	5.8e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—NFKBIA—atopic dermatitis	3.18e-06	5.8e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—NFKBIA—atopic dermatitis	3.18e-06	5.79e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—NFKBIA—atopic dermatitis	3.17e-06	5.77e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—NFKBIA—atopic dermatitis	3.16e-06	5.75e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—NFKBIA—atopic dermatitis	3.12e-06	5.7e-05	CbGpPWpGaD
Aripiprazole—HTR6—Signaling Pathways—MAPK8—atopic dermatitis	3.12e-06	5.69e-05	CbGpPWpGaD
Aripiprazole—HTR7—Signaling Pathways—MAPK8—atopic dermatitis	3.12e-06	5.69e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—NFKBIA—atopic dermatitis	3.12e-06	5.68e-05	CbGpPWpGaD
Aripiprazole—HTR1D—Signaling Pathways—MAPK8—atopic dermatitis	3.1e-06	5.65e-05	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling Pathways—IL2—atopic dermatitis	3.1e-06	5.65e-05	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling by GPCR—IL6—atopic dermatitis	3.08e-06	5.62e-05	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling Pathways—IL2—atopic dermatitis	3.06e-06	5.59e-05	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—CXCL8—atopic dermatitis	3.05e-06	5.57e-05	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling by GPCR—IL6—atopic dermatitis	3.05e-06	5.56e-05	CbGpPWpGaD
Aripiprazole—HTR1B—Signaling Pathways—MAPK8—atopic dermatitis	3.03e-06	5.53e-05	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—CXCL8—atopic dermatitis	3.01e-06	5.5e-05	CbGpPWpGaD
Aripiprazole—DRD4—Signaling Pathways—MAPK8—atopic dermatitis	2.98e-06	5.44e-05	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling Pathways—MAPK8—atopic dermatitis	2.94e-06	5.37e-05	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—IL2—atopic dermatitis	2.92e-06	5.32e-05	CbGpPWpGaD
Aripiprazole—HTR1E—Signaling Pathways—IL6—atopic dermatitis	2.92e-06	5.32e-05	CbGpPWpGaD
Aripiprazole—DRD1—Signaling by GPCR—IL6—atopic dermatitis	2.9e-06	5.3e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—NFKBIA—atopic dermatitis	2.9e-06	5.28e-05	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—IL2—atopic dermatitis	2.88e-06	5.25e-05	CbGpPWpGaD
Aripiprazole—DRD3—Signaling by GPCR—IL6—atopic dermatitis	2.87e-06	5.23e-05	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling Pathways—MAPK8—atopic dermatitis	2.85e-06	5.2e-05	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling Pathways—MAPK8—atopic dermatitis	2.82e-06	5.14e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—CXCL8—atopic dermatitis	2.75e-06	5.01e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—CXCL8—atopic dermatitis	2.72e-06	4.96e-05	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—PPARA—atopic dermatitis	2.71e-06	4.94e-05	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—MAPK8—atopic dermatitis	2.69e-06	4.9e-05	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—MAPK8—atopic dermatitis	2.65e-06	4.83e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—CXCL8—atopic dermatitis	2.63e-06	4.79e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—IL2—atopic dermatitis	2.62e-06	4.79e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—CXCL8—atopic dermatitis	2.61e-06	4.77e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling by GPCR—IL6—atopic dermatitis	2.61e-06	4.76e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—IL2—atopic dermatitis	2.6e-06	4.74e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling by GPCR—IL6—atopic dermatitis	2.59e-06	4.72e-05	CbGpPWpGaD
Aripiprazole—DRD5—Signaling Pathways—IL6—atopic dermatitis	2.58e-06	4.71e-05	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—PPARA—atopic dermatitis	2.55e-06	4.65e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—CXCL8—atopic dermatitis	2.54e-06	4.64e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—IL2—atopic dermatitis	2.51e-06	4.58e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—CXCL8—atopic dermatitis	2.5e-06	4.56e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling by GPCR—IL6—atopic dermatitis	2.5e-06	4.56e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—IL2—atopic dermatitis	2.5e-06	4.55e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling by GPCR—IL6—atopic dermatitis	2.49e-06	4.53e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—IL2—atopic dermatitis	2.43e-06	4.43e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling by GPCR—IL6—atopic dermatitis	2.42e-06	4.41e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—MAPK8—atopic dermatitis	2.42e-06	4.41e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—MAPK8—atopic dermatitis	2.39e-06	4.37e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—IL2—atopic dermatitis	2.39e-06	4.36e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling by GPCR—IL6—atopic dermatitis	2.38e-06	4.34e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—MAPK8—atopic dermatitis	2.31e-06	4.21e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—CXCL8—atopic dermatitis	2.31e-06	4.21e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—MAPK8—atopic dermatitis	2.3e-06	4.19e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—CXCL8—atopic dermatitis	2.27e-06	4.14e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—CXCL8—atopic dermatitis	2.26e-06	4.13e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—CXCL8—atopic dermatitis	2.26e-06	4.12e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—CXCL8—atopic dermatitis	2.25e-06	4.1e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—MAPK8—atopic dermatitis	2.24e-06	4.08e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—CXCL8—atopic dermatitis	2.23e-06	4.06e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—CXCL8—atopic dermatitis	2.22e-06	4.05e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—IL2—atopic dermatitis	2.2e-06	4.02e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—MAPK8—atopic dermatitis	2.2e-06	4.01e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling by GPCR—IL6—atopic dermatitis	2.19e-06	4e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—IL2—atopic dermatitis	2.17e-06	3.95e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—IL2—atopic dermatitis	2.16e-06	3.95e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling by GPCR—IL6—atopic dermatitis	2.16e-06	3.94e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—IL2—atopic dermatitis	2.16e-06	3.93e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling by GPCR—IL6—atopic dermatitis	2.15e-06	3.93e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—IL2—atopic dermatitis	2.15e-06	3.92e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling by GPCR—IL6—atopic dermatitis	2.15e-06	3.91e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling by GPCR—IL6—atopic dermatitis	2.14e-06	3.9e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—IL2—atopic dermatitis	2.13e-06	3.88e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—IL2—atopic dermatitis	2.12e-06	3.87e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling by GPCR—IL6—atopic dermatitis	2.12e-06	3.86e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling by GPCR—IL6—atopic dermatitis	2.11e-06	3.85e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—CXCL8—atopic dermatitis	2.06e-06	3.76e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—MAPK8—atopic dermatitis	2.03e-06	3.7e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—MAPK8—atopic dermatitis	2e-06	3.64e-05	CbGpPWpGaD
Aripiprazole—HTR6—Signaling Pathways—IL6—atopic dermatitis	1.99e-06	3.64e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—MAPK8—atopic dermatitis	1.99e-06	3.63e-05	CbGpPWpGaD
Aripiprazole—HTR7—Signaling Pathways—IL6—atopic dermatitis	1.99e-06	3.63e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—MAPK8—atopic dermatitis	1.99e-06	3.62e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—MAPK8—atopic dermatitis	1.98e-06	3.61e-05	CbGpPWpGaD
Aripiprazole—HTR1D—Signaling Pathways—IL6—atopic dermatitis	1.98e-06	3.61e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—IL2—atopic dermatitis	1.97e-06	3.6e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling by GPCR—IL6—atopic dermatitis	1.96e-06	3.58e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—MAPK8—atopic dermatitis	1.96e-06	3.57e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—MAPK8—atopic dermatitis	1.95e-06	3.56e-05	CbGpPWpGaD
Aripiprazole—HTR1B—Signaling Pathways—IL6—atopic dermatitis	1.94e-06	3.53e-05	CbGpPWpGaD
Aripiprazole—DRD4—Signaling Pathways—IL6—atopic dermatitis	1.91e-06	3.48e-05	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling Pathways—IL6—atopic dermatitis	1.88e-06	3.43e-05	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling Pathways—IL6—atopic dermatitis	1.82e-06	3.32e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—MAPK8—atopic dermatitis	1.82e-06	3.31e-05	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling Pathways—IL6—atopic dermatitis	1.8e-06	3.28e-05	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—IL6—atopic dermatitis	1.72e-06	3.13e-05	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—IL6—atopic dermatitis	1.69e-06	3.09e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—PPARA—atopic dermatitis	1.67e-06	3.04e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—IL6—atopic dermatitis	1.54e-06	2.81e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—IL6—atopic dermatitis	1.53e-06	2.79e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—IL6—atopic dermatitis	1.48e-06	2.69e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—IL6—atopic dermatitis	1.47e-06	2.68e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—IL6—atopic dermatitis	1.43e-06	2.6e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—IL6—atopic dermatitis	1.41e-06	2.56e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—IL6—atopic dermatitis	1.3e-06	2.36e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—IL6—atopic dermatitis	1.27e-06	2.32e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—IL6—atopic dermatitis	1.27e-06	2.32e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—IL6—atopic dermatitis	1.27e-06	2.31e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—IL6—atopic dermatitis	1.26e-06	2.3e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—IL6—atopic dermatitis	1.25e-06	2.28e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—IL6—atopic dermatitis	1.25e-06	2.28e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—IL6—atopic dermatitis	1.16e-06	2.11e-05	CbGpPWpGaD
